Volume 23, Number 7—July 2017
Recombinant GII.P16-GII.2 Norovirus, Taiwan, 2016
Highlight and copy the desired format.
|EID||Liu L, Kuo T, Wu C, Liao W, Hall AJ, Wu F, et al. Recombinant GII.P16-GII.2 Norovirus, Taiwan, 2016. Emerg Infect Dis. 2017;23(7):1180-1183. https://dx.doi.org/10.3201/eid2307.170212|
|AMA||Liu L, Kuo T, Wu C, et al. Recombinant GII.P16-GII.2 Norovirus, Taiwan, 2016. Emerging Infectious Diseases. 2017;23(7):1180-1183. doi:10.3201/eid2307.170212.|
|APA||Liu, L., Kuo, T., Wu, C., Liao, W., Hall, A. J., & Wu, F. (2017). Recombinant GII.P16-GII.2 Norovirus, Taiwan, 2016. Emerging Infectious Diseases, 23(7), 1180-1183. https://dx.doi.org/10.3201/eid2307.170212.|
In Taiwan, acute gastroenteritis outbreaks caused by a new norovirus genotype GII.2 increased sharply toward the end of 2016. Unlike previous outbreaks, which often involved restaurants, GII.2 outbreaks mainly occurred in schools. Phylogenetic analysis indicates that these noroviruses are recombinant GII.P16-GII.2 strains.
Norovirus, the leading global cause of epidemic gastroenteritis, is responsible for >90% of all viral gastroenteritis and ≈50% of gastroenteritis outbreaks worldwide (1). In Taiwan, variants of the genotype GII.4 had been the most prevalent genotype in norovirus-associated acute gastroenteritis outbreaks until mid-2014 (2). Since winter 2014–15, a previously uncommon genotype, GII.17, became the predominant genotype in Taiwan. This GII.17 strain also caused many outbreaks in Japan and was reported sporadically in other parts of the world (3,4). Since September 2016, we have identified a new GII.P16-GII.2 strain that has replaced GII.17 as the predominant strain in norovirus-associated outbreaks in Taiwan, concurrent with a sharp increase in GII.P16-GII.2 norovirus outbreaks and sporadic cases during the 2016–17 season in Germany (5).
During January 2015–December 2016, a total of 876 acute gastroenteritis outbreaks were reported to the Centers for Disease Control in Taiwan. A total of 576 (65.8%) outbreaks were identified as norovirus by reverse transcription PCR with primer pairs G1SKF/G1SKR and G2SKF/G2SKR for GI and GII genogroup detection, respectively; all positive samples underwent sequence-based genotyping by using the Norovirus Genotyping Tool (Table 1) (2,6,7). Before August 2016, GII.2 strains had been detected only sporadically (Figure 1). By September 2016, GII.2 accounted for 60% of norovirus-associated acute gastroenteritis outbreaks that month and, in December 2016, for 86%. Globally, GII.2 is an uncommon genotype that accounted for ≈1.2% of sporadic norovirus infections in children during 2004–2012; by contrast, GII.4 was responsible for 67.2% of norovirus infections during the same period (8). In 2016, the settings of outbreaks involving GII.2 differed from those of non-GII.2; most (72.0%) GII.2 outbreaks occurred in schools, whereas most non-GII.2 outbreaks occurred in restaurants (41.4%) and fewer occurred in schools (31.0%). Within schools, half of GII.2 outbreaks occurred in kindergartens, 33.3% in elementary schools, and 14.9% in junior/senior high schools and colleges/universities (Table 2).
Complete or near full-length open reading frame (ORF) 2 (viral protein [VP] 1) and partial ORF1 (RNA-dependent RNA polymerase [RdRp]) sequences were further obtained from 11 randomly selected Taiwan GII.2 2016 strains by different outbreak and month, as previously described (2). However, only 10 and 8 of the RdRp and VP1 sequences, respectively, were of sufficient quality and length for use in analysis. We identified the RdRp region of all GII.2 Taiwan strains as genotype GII.P16 (Figure 2, panel A). Phylogenetic trees were inferred from GII.P16 RdRp and GII.2 VP1 sequences, and in both trees, the GII.2 Taiwan strains form 2 major clusters: 2016 GII.2 Taiwan strains and pre-2016 Taiwan GII.2 strains (Figure 2). Before GII.P16-GII.2 strains appeared, GII.P16 polymerases were found in combination with other strains, such as GII.17 (GenBank accession no. KJ196286), GII.4 Sydney (GenBank accession no. LC175468), GII.10 (GenBank accession no. KC110854), GII.3 (GenBank accession no. KF944110), GII.16 (GenBank accession no. AY682551) in Japan, Korea, and Europe, and GII.13 (GenBank accession no. KM036380) in Taiwan (9–12). In 2014, GII.P16-GII.2 recombinant strains also were detected sporadically, accounting for only 2 (1.1%) of 170 GII strains in South Korea (12). However, these South Korean GII.P16-GII.2 recombinants (GenBank accession nos. KC110856, KC110857) are more similar to the pre-2016 Taiwan GII.P16-GII.2 strains than to the 2016 recombinants in ORF1 phylogenetic tree (Figure 2, panel A). Phylogenetic analysis of VP1 genes of South Korean strains also grouped them with pre-2016 Taiwan GII.P16-GII.2 strains (data not shown). During the 2016–17 norovirus season in Germany, GII.P16-GII.2 strains also were found in nearly half of outbreaks (31/65) and sporadic cases (29/65) (5). For the RdRp gene, the closest strains to 2016 Taiwan GII.P16-GII.2 strains are the 2016 Germany GII.P16-GII.2 strains (GenBank accession nos. KY357454, KY357459) and a 2016 Japan GII.P16-GII.4 recombinant strain (GenBank accession no. LC175468), which had 98.6%–99.4% identity (Figure 2, panel A) (10). In Japan, during the 2004 and 2007–2010 norovirus outbreaks, GII.2 strains mostly were associated with GII.P2 polymerase, and few that had GII.P16 polymerase were classified as recombinants. These recombinants are more closely related to pre-2016 Taiwan strains than to 2016 strains (Figure 2, panel A) (13). For the VP1 phylogenetic tree, 2016 Taiwan strains were most closely related to the Germany GII.P16-GII.2 strains (GenBank accession nos. KY357459, KY357454) and a Hong Kong GII.2 strain also sampled in 2016 (GenBank accession no. KY421044), which had 97.8%–99.0% identity, and more distantly to a 2011 US strain (GenBank accession no. KJ407074) and a 2012 Japan (GenBank accession no. LC145787) strain (95% identity for each). The pre-2016 Taiwan strains sampled from 2011–2015 outbreaks that were more closely related to Japan chimeric GII.P16-GII.2 strains that were identified during the 2009–10 and 2012–2014 outbreak seasons in Japan (13) (Figure 2, panel B). In both trees, all Taiwan GII.P16-GII.2 strains from 2016 form a cluster that shares close genetic distance (>99% similarity), regardless of the type of transmission or setting of the outbreaks, and the 2016 Taiwan and Germany GII.P16-GII.2 strains are too closely related to discern the difference, suggesting that these 2016 GII.P16-GII.2 strains descended from a recent ancestor that might have been imported and spread within a short time. Furthermore, the close relation of pre-2016 Taiwan GII.P16-GII.2 strains to Japan GII.P16-GII.2 strains and 2016 Taiwan GII.P16-GII.2 strains to 2016 Germany and Hong Kong GII.P16-GII.2 strains could indicate that the pre-2016 and 2016 waves of outbreaks each derived independently from GII.2 strains that were circulating elsewhere globally.
Analysis revealed that RdRp and VP1 of 2016 and pre-2016 Taiwan strains share higher degree of amino acid identity (>98%) than nucleotide identity (91%–93%), indicating more synonymous mutations between the 2 groups. Sites in VP1 that can be used to differentiate between pre-2016 and 2016 Taiwan GII.P16-GII.2 strains were identified as S71A, V335I, T344A, A354G, and D400E, of which 3 of the sites shared the same residue between the 2016 strains and the 1976 Snow Mountain strain (GenBank accession no. AY134748). However, previous studies have shown that for GII.2 strains, antibodies against the 1976 Snow Mountain strain can block and recognize strains as recent as 2010; thus the GII.2 strains have had only limited evolution in antigenic sites (14). Recent 2016 GII.P16-GII.2 strains became the predominant strains of norovirus-associated acute gastroenteritis in Taiwan (Figure 1), although whether they were involved in outbreaks before 2004 is unknown because norovirus monitoring in Taiwan did not begin until that year. The recent outbreaks illustrated the potential of GII.2 to turn from a sporadically detected strain into an unprecedented dominating strain.
We report the previously uncommon norovirus genotype GII.P16-GII.2 causing an epidemic in Taiwan in late 2016. Previously, GII.2 strains were infrequently reported among both sporadic cases and outbreaks in Taiwan and globally. Before 2014, variants of GII.4, such as New Orleans 2009 and Sydney 2012, followed this paradigm of emergence and rapid replacement every few years, but no non-GII.4 genotypes predominated until the 2014–15 season, when GII.17 emerged in Asia (4,8). The simultaneous detection and close relation of 2016 Taiwan GII.P16-GII.2 strains with 2016 Germany strains is of importance; given that the previous GII.17 epidemic was limited to Asia, the prevalence of GII.P16-GII.2 should be monitored to assess whether this could become the new predominant strains in other parts of the world. Continued surveillance and unified systems for norovirus typing are critical to monitor the emergence and impact of these and other new norovirus strains.
Mr. Tzu-Chi Liu is a microbiologist in the Viral Enteric and Diarrheal Diseases Laboratory, Taiwan Centers for Disease Control. His primary research interests include typing, phylogeny, and evolution of rotavirus and norovirus.
This study was supported in part by Taiwan Ministry of Health and Welfare research grants MOHW105-CDC-C-315-123301, MOHW106-CDC-C-315-133301, and MOHW106-CDC-C-315-114715 from CDC Taiwan.
- Patel MM, Hall AJ, Vinjé J, Parashar UD. Noroviruses: a comprehensive review. J Clin Virol. 2009;44:1–8.
- Wu FT, Chen HC, Yen C, Wu CY, Katayama K, Park Y, et al. Epidemiology and molecular characteristics of norovirus GII.4 Sydney outbreaks in Taiwan, January 2012-December 2013. J Med Virol. 2015;87:1462–70.
- Lee CC, Feng Y, Chen SY, Tsai CN, Lai MW, Chiu CH. Emerging norovirus GII.17 in Taiwan. Clin Infect Dis. 2015;61:1762–4.
- de Graaf M, van Beek J, Vennema H, Podkolzin AT, Hewitt J, Bucardo F, et al. Emergence of a novel GII.17 norovirus – End of the GII.4 era? Euro Surveill. 2015;20:21178.
- Niendorf S, Jacobsen S, Faber M, Eis-Hübinger AM, Hofmann J, Zimmermann O, et al. Steep rise in norovirus cases and emergence of a new recombinant strain GII.P16-GII.2, Germany, winter 2016. Euro Surveill. 2017;22:30447.
- Kojima S, Kageyama T, Fukushi S, Hoshino FB, Shinohara M, Uchida K, et al. Genogroup-specific PCR primers for detection of Norwalk-like viruses. J Virol Methods. 2002;100:107–14.
- Kroneman A, Vennema H, Deforche K, v d Avoort H, Peñaranda S, Oberste MS, et al. An automated genotyping tool for enteroviruses and noroviruses. J Clin Virol. 2011;51:121–5.
- Hoa Tran TN, Trainor E, Nakagomi T, Cunliffe NA, Nakagomi O. Molecular epidemiology of noroviruses associated with acute sporadic gastroenteritis in children: global distribution of genogroups, genotypes and GII.4 variants. J Clin Virol. 2013;56:185–93.
- Zhirakovskaia EV, Tikunov AY, Bodnev SA, Klemesheva VV, Netesov SV, Tikunova NV. Molecular epidemiology of noroviruses associated with sporadic gastroenteritis in children in Novosibirsk, Russia, 2003-2012. J Med Virol. 2015;87:740–53.
- Matsushima Y, Shimizu T, Ishikawa M, Komane A, Okabe N, Ryo A, et al. Complete genome sequence of a recombinant GII.P16-GII.4 norovirus detected in Kawasaki city, Japan, in 2016. Genome Announc. 2016;4:e01099–16.
- Ambert-Balay K, Bon F, Le Guyader F, Pothier P, Kohli E. Characterization of new recombinant noroviruses. J Clin Microbiol. 2005;43:5179–86.
- Truong TC, Than VT, Kim W. Evolutionary phylodynamics of Korean noroviruses reveals a novel GII.2/GII.10 recombination event. PLoS One. 2014;9:e113966.
- Iritani N, Kaida A, Abe N, Sekiguchi J, Kubo H, Takakura K, et al. Increase of GII.2 norovirus infections during the 2009-2010 season in Osaka City, Japan. J Med Virol. 2012;84:517–25.
- Swanstrom J, Lindesmith LC, Donaldson EF, Yount B, Baric RS. Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects. J Virol. 2014;88:829–37.
TablesCite This Article
- Page created: June 19, 2017
- Page last updated: June 19, 2017
- Page last reviewed: June 19, 2017
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)